Try GOLD - Free
US drug order to hit India pharma R&D
Mint Kolkata
|May 20, 2025
Innovator firms might lower their research budgets, impacting Indian CROs that rely on their outsourced projects
Indian pharmaceutical companies that provide research services could take a hit following US President Donald Trump's executive order on cutting prices of prescription drugs, analysts told Mint.
The order, which seeks a policy for the US to pay 'most-favoured-nation' price—lowest paid by comparable countries for certain drugs—may affect innovator companies more than generic drugmakers. Consequently, innovators may have to cut spending on research to reduce costs, analysts said.
"If you look at a contract research organisations... they would be impacted first. Because if you're cutting the prices by 30 to 80% for innovators, there's less incentive for them to put in most of the capex on these high-end products," said Tausif Shaikh, lead pharma analyst, BNP Paribas.
This story is from the May 20, 2025 edition of Mint Kolkata.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Kolkata
Mint Kolkata
Sugar Cosmetics set to raise ₹150 crore as losses widen
The beauty brand has been grappling with a severe cash crunch over the past six months
3 mins
May 14, 2026
Mint Kolkata
Flex-fuel vehicle plan caught in dilemma
The government's push for flex-fuel vehicle rollout is facing a classic chicken-and-egg stalemate.
2 mins
May 14, 2026
Mint Kolkata
Govt preps higher MSP, coal-gas shift
Amid heightened global volatility and supply chain disruptions due to the West Asia war, the Union cabinet on Wednesday cleared a series of proposals to support India’s food and energy security, including higher minimum support prices (MSPs) for key kharif crops and a coal gasification incentive scheme to reduce dependence on imported fuel.
2 mins
May 14, 2026
Mint Kolkata
Berger up on sector revival cues
Berger Paints India Ltd’s shares soared over 4% on Wednesday as volume growth bounced back to double digits at 11.8% in the March quarter (Q4FY26) after a gap of six quarters.
2 mins
May 14, 2026
Mint Kolkata
In Street chaos, a tiny set of stocks sees big returns
Beneath the gloom gripping Indian equities, a quiet rally is reshaping parts of the market. Even as foreign investors pull money out, crude prices climb and benchmark indices struggle, a narrow band of companies tied to infrastructure, industrials and commodities is emerging as a winner.
2 mins
May 14, 2026
Mint Kolkata
Profit booking limits paper gold rally post duty hike
Bulls holding paper gold booked profits big time after the Centre hiked the gold import duty by 9 percentage points overnight to save on precious foreign exchange amid elevated oil prices induced by the West Asia impasse.
1 mins
May 14, 2026
Mint Kolkata
Rupee may slide to 96-98 by December-end amid oil shock
The Indian rupee is sliding from one record low to another, but economists say assigning a precise trajectory to the currency has become increasingly difficult amid the US-Iran war and the resultant crude oil shock.
2 mins
May 14, 2026
Mint Kolkata
Skyroot ties founder Esops to rocket launch milestones
The homegrown space-tech startup recently raised $60 million at a valuation of $1.1 billion
2 mins
May 14, 2026
Mint Kolkata
‘Investors are in a wait-and-watch mode’
Despite the ongoing market volatility and geopolitical uncertainties, India remains firmly at the centre of global emerging market allocations, said Rahul Malhotra, region head of emerging markets and member of the global wealth management committee at Julius Baer Bank.
2 mins
May 14, 2026
Mint Kolkata
Jewellers adapt as import duty hike makes gold costlier
Companies are focusing on gold exchange schemes and lower-karat products to prevent a drop in sales volume.
2 mins
May 14, 2026
Listen
Translate
Change font size